Even with the S&P 500 near an all-time high, there are plenty of compelling growth, dividend, and value stocks to buy now.

The RMR Group (Nasdaq: RMR) today announced on behalf of its managed joint venture that it has facilitated a $1.0 billion ...

Reshma Kewalramani, the Mumbai-born CEO of Vertex Pharmaceuticals, secures a spot on Fortune's 2025 list of the 100 Most ...

Following these transactions, Kewalramani directly owns 115,968 shares of Vertex Pharmaceuticals. Based on InvestingPro analysis, the stock currently trades below its Fair Value, with analysts setting ...

NEW YORK, NY-Reshma Kewalramani, the Mumbai-born CEO of Vertex Pharmaceuticals, has been named one of the 100 Most Powerful ...

SERB Pharmaceuticals plans to buy Y-mAbs Pharmaceuticals in a $412 million all-cash deal. CorMedix bought Melinta ...

The postoperative pain management market is witnessing steady growth, driven by the rising number of surgical procedures globally and increasing awareness of effective pain control. Advancements in ...

Mars partners with biotech firm Pairwise to develop climate-resilient cacao using CRISPR technology, aiming to safeguard the ...

It’s a fair question — and one genuinely difficult to answer about a president who thrives on outrage and leans heavily into ...

Trikafta, for cystic fibrosis, is due to be added to WHO's Essential Medicines List. But its pricing means many patients are unable to access it. Sophie Cousins reports.

After telegraphing an investigation in November, the FDA has moved to restrict the use of bluebird bio’s gene therapy Skysona ...

Detailed price information for Arbutus Biopharma Corp (ABUS-Q) from The Globe and Mail including charting and trades.